PGP and neoplasm: TPGS, known for its P-gp inhibition and bioavailability-enhancing properties, is likely to contribute to the increased tumor retention of PTX and CUR by inhibiting P-gp-mediated efflux and, consequently, improve the therapeutic index of PTX in the PSCT treatment group.